Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Arthur J. Gallagher & Co. Director's Dealing 2023

Mar 14, 2023

29910_dirs_2023-03-14_9da14958-3f30-4920-84b8-85fabc830cd6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arthur J. Gallagher & Co. (AJG)
CIK: 0000354190
Period of Report: 2023-03-10

Reporting Person: GALLAGHER J PATRICK JR (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-03-12 Common Stock (restricted) A 68540 Acquired 68540 Direct
2023-03-12 Common Stock (restricted) M 68540 Disposed 0 Direct
2023-03-12 Common Stock M 68540 Acquired 135559.4435 Direct
2023-03-12 Common Stock F 29633 $182.76 Disposed 105926.4435 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-03-10 Phantom Stock $ I 12100 Acquired Common Stock (12100) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 23448 Indirect
Common Stock 255965 Indirect
Common Stock 94888 Indirect
Common Stock 241756 Indirect
Common Stock 218485 Indirect
Common Stock 214.625 Indirect

Footnotes

F1: Performance share units (awarded on March 12, 2020) earned and vested as of March 12, 2023.

F2: Shares held in trust for the benefit of my children of which I am sole Trustee.

F3: Shares held in revocable trust of which my spouse is sole Trustee and as to which I disclaim beneficial ownership.

F4: Held in trust for benefit of children.

F5: Each share of phantom stock represents a right to receive one share of Gallagher common stock.

F6: These shares represent awards under the Age 62 Plan, a nonqualified deferred compensation plan of the Company, which have been deemed invested in Company common stock at the election of the reporting person. Participants vest in these awards when they attain age 62, or after a one-year period for participants who have attained age 61.